These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34783719)
1. 18F-FDG PET/CT for the evaluation of male breast cancer: a systematic review. Dondi F; Albano D; Giubbini R; Bertagna F Nucl Med Commun; 2022 Feb; 43(2):123-128. PubMed ID: 34783719 [TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review. Dondi F; Albano D; Giubbini R; Bertagna F Nucl Med Commun; 2021 Dec; 42(12):1293-1300. PubMed ID: 34456317 [TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodeoxyglucose PET and PET/computed tomography for the evaluation of immunoglobulin G4-related disease: a systematic review. Dondi F; Albano D; Bellini P; Volpi G; Giubbini R; Bertagna F Nucl Med Commun; 2022 Jun; 43(6):638-645. PubMed ID: 35438679 [TBL] [Abstract][Full Text] [Related]
4. Detection of distant interval metastases after neoadjuvant therapy for esophageal cancer with 18F-FDG PET(/CT): a systematic review and meta-analysis. Kroese TE; Goense L; van Hillegersberg R; de Keizer B; Mook S; Ruurda JP; van Rossum PSN Dis Esophagus; 2018 Dec; 31(12):. PubMed ID: 29917073 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Value of 18F-FDG PET/CT in Male Breast Cancer: Results From a Bicentric Population. Evangelista L; Bertagna F; Bertoli M; Stela T; Saladini G; Giubbini R Curr Radiopharm; 2016; 9(2):169-77. PubMed ID: 26018128 [TBL] [Abstract][Full Text] [Related]
6. Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):220-224. PubMed ID: 32522411 [TBL] [Abstract][Full Text] [Related]
7. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer. Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086 [TBL] [Abstract][Full Text] [Related]
8. Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma. Vaarwerk B; Breunis WB; Haveman LM; de Keizer B; Jehanno N; Borgwardt L; van Rijn RR; van den Berg H; Cohen JF; van Dalen EC; Merks JH Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012325. PubMed ID: 34753195 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis. Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747 [TBL] [Abstract][Full Text] [Related]
10. Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis. Zhang C; Liang Z; Liu W; Zeng X; Mo Y BMC Cancer; 2023 Jan; 23(1):37. PubMed ID: 36624425 [TBL] [Abstract][Full Text] [Related]
11. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation. Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472 [TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513 [TBL] [Abstract][Full Text] [Related]
13. Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men? Vatankulu B; Işik G; Kocael P; Kuyumcu S; Ilvan Ş; Sağer S; Halaç M; Türkmen C; Sönmezoğlu K Nucl Med Commun; 2016 Dec; 37(12):1273-1281. PubMed ID: 27472037 [TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging. Caresia Aroztegui AP; García Vicente AM; Alvarez Ruiz S; Delgado Bolton RC; Orcajo Rincon J; Garcia Garzon JR; de Arcocha Torres M; Garcia-Velloso MJ; Tumour Biol; 2017 Oct; 39(10):1010428317728285. PubMed ID: 29025377 [TBL] [Abstract][Full Text] [Related]
15. The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review. Quartuccio N; Salem A; Laudicella R; Spataro A; Chiaravalloti A; Caobelli F; Cistaro A; Alongi P; Evangelista L Nucl Med Commun; 2021 Aug; 42(8):839-845. PubMed ID: 33741854 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer. Vadi SK; Mittal BR; Sood A; Singh G; Bal A; Parihar AS; Bhattacharya A; Basher RK; Kapoor R Nucl Med Commun; 2019 Jan; 40(1):63-72. PubMed ID: 30312217 [TBL] [Abstract][Full Text] [Related]
17. The Diagnostic Value of Bang JI; Park S; Kim K; Seo Y; Chong A; Hong CM; Choi M; Lee SW; Oh SW Thyroid; 2023 Oct; 33(10):1224-1236. PubMed ID: 37597200 [No Abstract] [Full Text] [Related]
18. Diagnostic value of [18F]FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis. van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Sandovici M; Jamar F; Gheysens O; Slart RHJA Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3886-3902. PubMed ID: 33942141 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of [18F]FDG-PET/CT in polymyalgia rheumatica: a systematic review and meta-analysis. van der Geest KSM; Treglia G; Glaudemans AWJM; Brouwer E; Jamar F; Slart RHJA; Gheysens O Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1876-1889. PubMed ID: 33372248 [TBL] [Abstract][Full Text] [Related]
20. The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis. Nuvoli S; Fiore V; Babudieri S; Galassi S; Bagella P; Solinas P; Spanu A; Madeddu G Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1744-1751. PubMed ID: 29630121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]